PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
49.06
ESG score 40-50 - Concerning ESG levels. Seth Klarman would demand significant margin of safety given potential regulatory and reputational risks.
63.54
Environmental score 60-70 - Adequate environmental stewardship that Peter Lynch might accept. Verify if climate risk management protects long-term cash flows.
31.02
Social score below 40 - Social license danger zone. Howard Marks would warn of heightened reputational, litigation, and regulatory risks. Essential to examine stakeholder relations.
52.63
Governance score 50-60 - Below-average governance territory. Benjamin Graham would scrutinize management entrenchment and potential agency costs.